Multidrug-Resistant Hypervirulent Group B<i>Streptococcus</i>in Neonatal Invasive Infections, France, 2007–2019
Céline Plainvert, Constantin Hays, Gérald Touak, Caroline Joubrel-Guyot, Nicolas Dmytruk, Amandine Frigo, Claire Poyart, Asmaa Tazi
Abstract
We analyzed group B Streptococcus (GBS) neonatal invasive infections reported during 2007-2019 in France. The hypervirulent clonal complex (CC) 17 GBS was responsible for 66% (827/1,262) of cases. The role of CC17 GBS increased over time (p for trend = 0.0001), together with the emergence of a multidrug-resistant CC17 GBS sublineage.
Topics & Concepts
Multiple drug resistanceStreptococcusGroup BMicrobiologyMedicineVirologyBiologyDrug resistanceGeneticsInternal medicineBacteriaNeonatal and Maternal InfectionsStreptococcal Infections and TreatmentsBacterial Identification and Susceptibility Testing